Willy Cowles practices corporate law with a focus on emerging companies across a wide variety of industries and stages of development. He has experience with corporate formation, venture capital financings, M&A and capital markets, Willy also has substantial experience in all aspects of private fund formation, including corporate, transactional and regulatory matters arising in connection with the formation and operation of US and offshore private equity funds, venture capital funds and hedge funds.

Download full bio 


  • Eliem Therapeutics – $92 Million IPO 

  • Resolution Bio Sells to Agilent 

  • Rodeo Therapeutics Agrees to Sell to Amgen for $721 Million 


  • Northwestern University Pritzker School of Law
    JD, cum laude, 2019

  • Hamilton College
    BA, History
    cum laude, 2009

Admissions & Credentials